메뉴 건너뛰기




Volumn 7, Issue 6, 2008, Pages 714-719

JAK2 activation in myeloproliferative neoplasms: A potential role for heterodimeric receptors

Author keywords

Cytokine receptor; IL27Ra; JAK2; JAK2 V617F; Myeloproliferative disorder; Myeloproliferative neoplasm

Indexed keywords

CYTOKINE RECEPTOR; HETERODIMER; JANUS KINASE 2; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; V617F PROTEIN;

EID: 42049083776     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.6.5567     Document Type: Review
Times cited : (12)

References (76)
  • 1
    • 33750522675 scopus 로고    scopus 로고
    • Jaks and cytokine receptors - an intimate relationship
    • Haan C, Kreis S, Margue C, Behrmann I. Jaks and cytokine receptors - an intimate relationship. Biochem Pharmacol 2006; 72:1538-46.
    • (2006) Biochem Pharmacol , vol.72 , pp. 1538-1546
    • Haan, C.1    Kreis, S.2    Margue, C.3    Behrmann, I.4
  • 2
    • 0028845212 scopus 로고
    • Cytokine receptor signalling
    • Ihle JN. Cytokine receptor signalling. Nature 1995; 377:591-4.
    • (1995) Nature , vol.377 , pp. 591-594
    • Ihle, J.N.1
  • 3
    • 0034693871 scopus 로고    scopus 로고
    • Janus kinases: Components of multiple signaling pathways
    • Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene 2000; 19:5662-79.
    • (2000) Oncogene , vol.19 , pp. 5662-5679
    • Rane, S.G.1    Reddy, E.P.2
  • 5
    • 35348850734 scopus 로고    scopus 로고
    • Hematopoietic cytokine receptor signaling
    • Baker SJ, Rane SG, Reddy EP. Hematopoietic cytokine receptor signaling. Oncogene 2007; 26:6724-37.
    • (2007) Oncogene , vol.26 , pp. 6724-6737
    • Baker, S.J.1    Rane, S.G.2    Reddy, E.P.3
  • 7
    • 0037033012 scopus 로고    scopus 로고
    • The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction
    • Saharinen P, Silvennoinen O. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J Biol Chem 2002; 277:47954-63.
    • (2002) J Biol Chem , vol.277 , pp. 47954-47963
    • Saharinen, P.1    Silvennoinen, O.2
  • 8
    • 0034012330 scopus 로고    scopus 로고
    • Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
    • Saharinen P, Takaluoma K, Silvennoinen O. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol 2000; 20:3387-95.
    • (2000) Mol Cell Biol , vol.20 , pp. 3387-3395
    • Saharinen, P.1    Takaluoma, K.2    Silvennoinen, O.3
  • 9
    • 29644439240 scopus 로고    scopus 로고
    • JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: Cross-talk with IGF1 receptor
    • Staerk J, Kallin A, Demoulin JB, Vainchenker W, Constantinescu SN. JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J Biol Chem 2005; 280:41893-9.
    • (2005) J Biol Chem , vol.280 , pp. 41893-41899
    • Staerk, J.1    Kallin, A.2    Demoulin, J.B.3    Vainchenker, W.4    Constantinescu, S.N.5
  • 10
    • 0036731485 scopus 로고    scopus 로고
    • Stats: Transcriptional control and biological impact
    • Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3:651-62.
    • (2002) Nat Rev Mol Cell Biol , vol.3 , pp. 651-662
    • Levy, D.E.1    Darnell Jr, J.E.2
  • 11
    • 25844469587 scopus 로고    scopus 로고
    • Griesinger F, Hennig H, Hillmer F, Podleschny M, Steffens R, Pies A, Wormann B, Haase D, Bohlander SK. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia. Genes Chromosomes Cancer 2005; 44:329-33. 12. Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood 2000; 95:2076-83.
    • Griesinger F, Hennig H, Hillmer F, Podleschny M, Steffens R, Pies A, Wormann B, Haase D, Bohlander SK. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia. Genes Chromosomes Cancer 2005; 44:329-33. 12. Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood 2000; 95:2076-83.
  • 12
    • 0030852328 scopus 로고    scopus 로고
    • Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 1997; 90:2535-40.
    • Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 1997; 90:2535-40.
  • 14
    • 33947328520 scopus 로고    scopus 로고
    • Oncogenes in myeloproliferative disorders
    • Tefferi A, Gilliland DG. Oncogenes in myeloproliferative disorders. Cell Cycle 2007; 6:550-66.
    • (2007) Cell Cycle , vol.6 , pp. 550-566
    • Tefferi, A.1    Gilliland, D.G.2
  • 17
    • 33846216449 scopus 로고    scopus 로고
    • Jak2: Normal function and role in hematopoietic disorders
    • Ihle JN, Gilliland DG. Jak2: normal function and role in hematopoietic disorders. Curr Opin Genet Dev 2007; 17:8-14.
    • (2007) Curr Opin Genet Dev , vol.17 , pp. 8-14
    • Ihle, J.N.1    Gilliland, D.G.2
  • 18
    • 0029031668 scopus 로고
    • Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects
    • Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. Embo J 1995; 14:2857-65.
    • (1995) Embo J , vol.14 , pp. 2857-2865
    • Harrison, D.A.1    Binari, R.2    Nahreini, T.S.3    Gilman, M.4    Perrimon, N.5
  • 19
    • 0028938172 scopus 로고
    • An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects
    • Luo H, Hanratty WP, Dearolf CR. An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects. Embo J 1995; 14:1412-20.
    • (1995) Embo J , vol.14 , pp. 1412-1420
    • Luo, H.1    Hanratty, W.P.2    Dearolf, C.R.3
  • 21
    • 33845436745 scopus 로고    scopus 로고
    • The myeloproliferative disorders
    • Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med 2006; 355:2452-66.
    • (2006) N Engl J Med , vol.355 , pp. 2452-2466
    • Campbell, P.J.1    Green, A.R.2
  • 22
    • 0001639195 scopus 로고
    • Some speculations on the myeloproliferative syndromes
    • Dameshek W. Some speculations on the myeloproliferative syndromes. Blood 1951; 6:372-5.
    • (1951) Blood , vol.6 , pp. 372-375
    • Dameshek, W.1
  • 23
    • 34548240698 scopus 로고    scopus 로고
    • Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders
    • Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7:673-83.
    • (2007) Nat Rev Cancer , vol.7 , pp. 673-683
    • Levine, R.L.1    Pardanani, A.2    Tefferi, A.3    Gilliland, D.G.4
  • 28
    • 20744460045 scopus 로고    scopus 로고
    • Identification of an acquired JAK2 mutation in polycythemia vera
    • Zhao R, Xing S, Li Z, Fu X, Li Q, Krantz SB, Zhao ZJ. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem 2005; 280:22788-92.
    • (2005) J Biol Chem , vol.280 , pp. 22788-22792
    • Zhao, R.1    Xing, S.2    Li, Z.3    Fu, X.4    Li, Q.5    Krantz, S.B.6    Zhao, Z.J.7
  • 30
    • 33845355846 scopus 로고    scopus 로고
    • JAK-2 mutations and their relevance to myeloproliferative disease
    • Levine RL, Gilliland DG. JAK-2 mutations and their relevance to myeloproliferative disease. Curr Opin Hematol 2007; 14:43-7.
    • (2007) Curr Opin Hematol , vol.14 , pp. 43-47
    • Levine, R.L.1    Gilliland, D.G.2
  • 31
    • 42049086740 scopus 로고    scopus 로고
    • A Role for JAK2 Mutations in Myeloproliferative Diseases
    • Morgan KJ, Gilliland DG. A Role for JAK2 Mutations in Myeloproliferative Diseases. Annu Rev Med 2007.
    • (2007) Annu Rev Med
    • Morgan, K.J.1    Gilliland, D.G.2
  • 32
    • 34848840612 scopus 로고    scopus 로고
    • Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders
    • Pikman Y, Levine RL. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders. Curr Opin Oncol 2007; 19:628-34.
    • (2007) Curr Opin Oncol , vol.19 , pp. 628-634
    • Pikman, Y.1    Levine, R.L.2
  • 34
    • 25444513652 scopus 로고    scopus 로고
    • JAK2 in myeloproliferative disorders is not just another kinase
    • Tefferi A, Gilliland DG. JAK2 in myeloproliferative disorders is not just another kinase. Cell Cycle 2005; 4:1053-6.
    • (2005) Cell Cycle , vol.4 , pp. 1053-1056
    • Tefferi, A.1    Gilliland, D.G.2
  • 36
    • 39749130423 scopus 로고    scopus 로고
    • JAK2 mutations and clinical practice in myeloproliferative neoplasms
    • Tefferi A. JAK2 mutations and clinical practice in myeloproliferative neoplasms. Cancer J 2007; 13:366-71.
    • (2007) Cancer J , vol.13 , pp. 366-371
    • Tefferi, A.1
  • 37
    • 38549152801 scopus 로고    scopus 로고
    • Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
    • Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007.
    • (2007) Leukemia
    • Tefferi, A.1    Vardiman, J.W.2
  • 39
    • 33745721197 scopus 로고    scopus 로고
    • JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
    • Lacout C, Pisani DF, Tulliez M, Gachelin FM, Vainchenker W, Villeval JL. JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 2006; 108:1652-60.
    • (2006) Blood , vol.108 , pp. 1652-1660
    • Lacout, C.1    Pisani, D.F.2    Tulliez, M.3    Gachelin, F.M.4    Vainchenker, W.5    Villeval, J.L.6
  • 40
    • 33744490974 scopus 로고    scopus 로고
    • Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
    • Wernig G, Mercher T, Okabe R, Levine RL, Lee BH, Gilliland DG. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 2006; 107:4274-81.
    • (2006) Blood , vol.107 , pp. 4274-4281
    • Wernig, G.1    Mercher, T.2    Okabe, R.3    Levine, R.L.4    Lee, B.H.5    Gilliland, D.G.6
  • 42
    • 85011937299 scopus 로고    scopus 로고
    • Tiedt R, Hao Shen H, Sobas MA, Looser R, Dirnhofer S, Schwaller J, Skoda RC. Ratio of mutant JAK2-V617F to wild type JAK2 determines the MPD phenotypes in transgenic mice. Blood 2007.
    • Tiedt R, Hao Shen H, Sobas MA, Looser R, Dirnhofer S, Schwaller J, Skoda RC. Ratio of mutant JAK2-V617F to wild type JAK2 determines the MPD phenotypes in transgenic mice. Blood 2007.
  • 43
    • 42049102005 scopus 로고    scopus 로고
    • The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders
    • Bellanne Chantelot C, Jego P, Lionne Huyghe P, Tulliez M, Najman A. The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders. Leukemia 2007.
    • (2007) Leukemia
    • Bellanne Chantelot, C.1    Jego, P.2    Lionne Huyghe, P.3    Tulliez, M.4    Najman, A.5
  • 44
    • 33750611344 scopus 로고    scopus 로고
    • Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera
    • Ishii T, Bruno E, Hoffman R, Xu M. Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera. Blood 2006; 108:3128-34.
    • (2006) Blood , vol.108 , pp. 3128-3134
    • Ishii, T.1    Bruno, E.2    Hoffman, R.3    Xu, M.4
  • 45
    • 33747199312 scopus 로고    scopus 로고
    • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
    • Kralovics R, Teo SS, Li S, Theocharides A, Buser AS, Tichelli A, Skoda RC. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 2006; 108:1377-80.
    • (2006) Blood , vol.108 , pp. 1377-1380
    • Kralovics, R.1    Teo, S.S.2    Li, S.3    Theocharides, A.4    Buser, A.S.5    Tichelli, A.6    Skoda, R.C.7
  • 49
  • 51
    • 34547673400 scopus 로고    scopus 로고
    • Applying the discovery of the Philadelphia chromosome
    • Sherbenou DW, Druker BJ. Applying the discovery of the Philadelphia chromosome. J Clin Invest 2007; 117:2067-74.
    • (2007) J Clin Invest , vol.117 , pp. 2067-2074
    • Sherbenou, D.W.1    Druker, B.J.2
  • 52
    • 38149123436 scopus 로고    scopus 로고
    • JAK2 inhibitor therapy in myeloproliferative disorders: Rationale, preclinical studies and ongoing clinical trials
    • Pardanani A. JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials. Leukemia 2007.
    • (2007) Leukemia
    • Pardanani, A.1
  • 57
    • 42049115866 scopus 로고    scopus 로고
    • Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F
    • Lu X, Huang LJ, Lodish HF. Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F. J Biol Chem 2007.
    • (2007) J Biol Chem
    • Lu, X.1    Huang, L.J.2    Lodish, H.F.3
  • 60
    • 2542502506 scopus 로고    scopus 로고
    • Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
    • Ding J, Komatsu H, Wakita A, Kato Uranishi M, Ito M, Satoh A, Tsuboi K, Nitta M, Miyazaki H, Iida S, Ueda R. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 2004; 103:4198-200.
    • (2004) Blood , vol.103 , pp. 4198-4200
    • Ding, J.1    Komatsu, H.2    Wakita, A.3    Kato Uranishi, M.4    Ito, M.5    Satoh, A.6    Tsuboi, K.7    Nitta, M.8    Miyazaki, H.9    Iida, S.10    Ueda, R.11
  • 61
    • 36749024030 scopus 로고    scopus 로고
    • Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor
    • Pradhan A, Lambert QT, Reuther GW. Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor. Proc Natl Acad Sci USA 2007; 104:18502-7.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 18502-18507
    • Pradhan, A.1    Lambert, Q.T.2    Reuther, G.W.3
  • 63
    • 3142709474 scopus 로고    scopus 로고
    • Understanding the pro- and anti-inflammatory properties of IL-27
    • Villarino AV, Huang E, Hunter CA. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004; 173:715-20.
    • (2004) J Immunol , vol.173 , pp. 715-720
    • Villarino, A.V.1    Huang, E.2    Hunter, C.A.3
  • 66
    • 85011940493 scopus 로고    scopus 로고
    • Seita J, Asakawa M, Ooehara J, Takayanagi SI, Morita Y, Watanabe N, Fujita K, Kudo M, Mizuguchi J, Ema H, Nakauchi H, Yoshimoto T. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 2007.
    • Seita J, Asakawa M, Ooehara J, Takayanagi SI, Morita Y, Watanabe N, Fujita K, Kudo M, Mizuguchi J, Ema H, Nakauchi H, Yoshimoto T. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 2007.
  • 67
    • 21844444831 scopus 로고    scopus 로고
    • Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5:521-31.
    • Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5:521-31.
  • 69
    • 0346157324 scopus 로고    scopus 로고
    • Acquiring signalling specificity from the cytokine receptor gp130
    • Ernst M, Jenkins BJ. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 2004; 20:23-32.
    • (2004) Trends Genet , vol.20 , pp. 23-32
    • Ernst, M.1    Jenkins, B.J.2
  • 70
    • 0026073694 scopus 로고
    • Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells
    • Hilton DJ, Nicola NA, Metcalf D. Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells. J Cell Physiol 1991; 146:207-15.
    • (1991) J Cell Physiol , vol.146 , pp. 207-215
    • Hilton, D.J.1    Nicola, N.A.2    Metcalf, D.3
  • 71
    • 12644294970 scopus 로고    scopus 로고
    • Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
    • Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 1996; 271:32635-43.
    • (1996) J Biol Chem , vol.271 , pp. 32635-32643
    • Mosley, B.1    De Imus, C.2    Friend, D.3    Boiani, N.4    Thoma, B.5    Park, L.S.6    Cosman, D.7
  • 72
    • 0030890718 scopus 로고    scopus 로고
    • Gp130 and the interleukin-6 family of cytokines
    • Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997; 15:797-819.
    • (1997) Annu Rev Immunol , vol.15 , pp. 797-819
    • Taga, T.1    Kishimoto, T.2
  • 73
    • 0034007126 scopus 로고    scopus 로고
    • Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): Gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells
    • Tomida M. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells. Leuk Lymphoma 2000; 37:517-25.
    • (2000) Leuk Lymphoma , vol.37 , pp. 517-525
    • Tomida, M.1
  • 74
    • 33750221616 scopus 로고    scopus 로고
    • Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2
    • Funakoshi Tago M, Pelletier S, Matsuda T, Parganas E, Ihle JN. Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. Embo J 2006; 25:4763-72.
    • (2006) Embo J , vol.25 , pp. 4763-4772
    • Funakoshi Tago, M.1    Pelletier, S.2    Matsuda, T.3    Parganas, E.4    Ihle, J.N.5
  • 75
    • 33646381647 scopus 로고    scopus 로고
    • Active conformation of the erythropoietin receptor: Random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains
    • Lu X, Gross AW, Lodish HF. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem 2006; 281:7002-11.
    • (2006) J Biol Chem , vol.281 , pp. 7002-7011
    • Lu, X.1    Gross, A.W.2    Lodish, H.F.3
  • 76
    • 0028332086 scopus 로고
    • Activation and inhibition of erythropoietin receptor function: Role of receptor dimerization
    • Watowich SS, Hilton DJ, Lodish HF. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol 1994; 14:3535-49.
    • (1994) Mol Cell Biol , vol.14 , pp. 3535-3549
    • Watowich, S.S.1    Hilton, D.J.2    Lodish, H.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.